treatment guidelines

Guideline Updates

Multiple Treatment Guideline Updates Released for Lung Cancer

05/19/2020

The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...

The...

05/19/2020

Journal of Clinical Pathways

Interview

Prostate Cancer Treatment Varies Between General Population, Diagnosed Men

01/11/2019

JCP Editors

Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...

...

01/11/2019

Journal of Clinical Pathways

Research in Review

Does Delayed Lymph Node Biopsy Affect Survival Rates in Melanoma?

06/29/2017

JCP Editors

Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...

Recent...

06/29/2017

Journal of Clinical Pathways

Research in Review

PARP Inhibitors Crucial to the Future of Ovarian Cancer Treatment

06/12/2017

JCP Editors

The treatment landscape in the coming decade for ovarian cancers will likely feature poly ADP ribose polymerase (PARP) inhibitors in combination with other treatments, according to reports from a recent...

The...

06/12/2017

Journal of Clinical Pathways

Research in Review

Standard of Care Shift in ALK-Positive Lung Cancer

06/12/2017

JCP Editors

A second-generation inhibitor delays anaplastic lymphoma kinase (ALK)-positive lung cancer growth for a median of 15 months longer and causes fewer adverse events than the current standard of care, according to a new...

A...

06/12/2017

Journal of Clinical Pathways

Research in Review

Polypharmacy and Inappropriate Medications Negatively Impact Older Patients With NHL

06/07/2017

JCP Editors

Older patients with non-Hodgkin lymphoma (NHL) who take potentially inappropriate medications increase the risk of adverse survival impacts, according to research presented at the 2017 ASCO Annual Meeting (June 2-6,...

Older...

06/07/2017

Journal of Clinical Pathways

Research in Review

Breast Cancer HER2 Status Conversion After Neoadjuvant Chemo Guides Further Therapy

05/30/2017

JCP Editors

Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...

...

05/30/2017

Journal of Clinical Pathways

Research in Review

HPV Vaccine Underutilized Despite Significant Oral HPV Infection Protection

05/30/2017

JCP Editors

Research presented at the 2017 American Society of Clinical Oncology showed that although human papillomavirus (HPV) vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and...

...

05/30/2017

Journal of Clinical Pathways

Research in Review

MRI Results After DCIS Biopsy Unreliable, Leads to Overtreatment

05/04/2017

JCP Editors

MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...

MRI...

05/04/2017

Journal of Clinical Pathways

Research in Review

International Guidelines Issued for Management of Sepsis, Septic Shock

03/15/2017

JCP Editors

The Surviving Sepsis Campaign, with the Society of Critical Care Management and the European Society of Intensive Care Medicine, published international guidelines for the management of sepsis and septic shock in...

The...

03/15/2017

Journal of Clinical Pathways